Harvey E. Behrend

Array ( [id] => 3702799 [patent_doc_number] => 05674882 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Retroviral protease inhibiting compounds' [patent_app_type] => 1 [patent_app_number] => 8/413136 [patent_app_country] => US [patent_app_date] => 1995-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54155 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674882.pdf [firstpage_image] =>[orig_patent_app_number] => 413136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3659344 [patent_doc_number] => 05591760 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-07 [patent_title] => 'Synergistic microbicidal combinations containing 4,5-dichloro-2-octyl-3-isothiazolone and certain commercial biocides' [patent_app_type] => 1 [patent_app_number] => 8/410165 [patent_app_country] => US [patent_app_date] => 1995-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3978 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/591/05591760.pdf [firstpage_image] =>[orig_patent_app_number] => 410165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3589745 [patent_doc_number] => 05585367 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'Method of treating humans and animals infected with viruses of the retrovirus group' [patent_app_type] => 1 [patent_app_number] => 8/406143 [patent_app_country] => US [patent_app_date] => 1995-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9407 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585367.pdf [firstpage_image] =>[orig_patent_app_number] => 406143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3657353 [patent_doc_number] => 05622959 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'Method of treating retroviral infections in mammals' [patent_app_type] => 1 [patent_app_number] => 8/397936 [patent_app_country] => US [patent_app_date] => 1995-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 5891 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/622/05622959.pdf [firstpage_image] =>[orig_patent_app_number] => 397936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3810121 [patent_doc_number] => 05811464 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Use of 2-methylamino-2-phenylcyclohexanone for the treatment of bacterial, fungal, virus or protozoan infections as well as for immunomodulation' [patent_app_type] => 1 [patent_app_number] => 8/404171 [patent_app_country] => US [patent_app_date] => 1995-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 2028 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811464.pdf [firstpage_image] =>[orig_patent_app_number] => 404171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3582671 [patent_doc_number] => 05580884 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-03 [patent_title] => 'Deoxygalactonojirimycin derivatives' [patent_app_type] => 1 [patent_app_number] => 8/396989 [patent_app_country] => US [patent_app_date] => 1995-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 23 [patent_no_of_words] => 7000 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/580/05580884.pdf [firstpage_image] =>[orig_patent_app_number] => 396989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3662313 [patent_doc_number] => 05624945 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Use of riluzole for the treatment of neuro-aids' [patent_app_type] => 1 [patent_app_number] => 8/396106 [patent_app_country] => US [patent_app_date] => 1995-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1052 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/624/05624945.pdf [firstpage_image] =>[orig_patent_app_number] => 396106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3686717 [patent_doc_number] => 05663161 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Anti-viral triaza compounds' [patent_app_type] => 1 [patent_app_number] => 8/392550 [patent_app_country] => US [patent_app_date] => 1995-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7445 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663161.pdf [firstpage_image] =>[orig_patent_app_number] => 392550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1235946 [patent_doc_number] => 06689761 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-10 [patent_title] => 'Combination therapy for HIV infection' [patent_app_type] => B1 [patent_app_number] => 08/382113 [patent_app_country] => US [patent_app_date] => 1995-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3006 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689761.pdf [firstpage_image] =>[orig_patent_app_number] => 08382113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3113693 [patent_doc_number] => 05464869 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-07 [patent_title] => 'Use of dimercaptan acids, salts and metabolites thereof as antiretroviral treatments' [patent_app_type] => 1 [patent_app_number] => 8/380787 [patent_app_country] => US [patent_app_date] => 1995-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4091 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/464/05464869.pdf [firstpage_image] =>[orig_patent_app_number] => 380787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3635104 [patent_doc_number] => 05631288 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-20 [patent_title] => 'Therapeutic method of treating patients suffering from AIDS and AIDS-related syndromes and asymptomatic HIV-seropositive patients.' [patent_app_type] => 1 [patent_app_number] => 8/370357 [patent_app_country] => US [patent_app_date] => 1995-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1609 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/631/05631288.pdf [firstpage_image] =>[orig_patent_app_number] => 370357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3609440 [patent_doc_number] => 05589503 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'Endoparasiticidal compositions' [patent_app_type] => 1 [patent_app_number] => 8/368515 [patent_app_country] => US [patent_app_date] => 1995-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14907 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589503.pdf [firstpage_image] =>[orig_patent_app_number] => 368515 [rel_patent_id] =>[rel_patent_doc_number] =>)